Non-Hodgkin LymphomaSymptoms, Doctors, Treatments, Advances & More
Non-Hodgkin Lymphoma Overview
Learn About Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma (NHL) is cancer of the lymph tissue. Lymph tissue is found in the lymph nodes, spleen, and other organs of the immune system.
White blood cells, called lymphocytes, are found in lymph tissue. They help prevent infections. Most lymphomas start in a type of white blood cell called the B lymphocyte, or B cell.
Lymphoma - non-Hodgkin; Lymphocytic lymphoma; Histiocytic lymphoma; Lymphoblastic lymphoma; Cancer - non-Hodgkin lymphoma; NHL; Non-Hodgkin's lymphoma
Common conditions include: Primary Mediastinal B-Cell Lymphoma (PMBCL)
For most people, the cause of NHL is unknown. But lymphomas may develop in people with weakened immune systems, including people who have had an organ transplant or people with HIV infection or Epstein-Barr virus infection.
NHL most often affects adults. Men develop NHL more often than women. Children can also develop some forms of NHL.
There are many types of NHL. One classification (grouping) is by how fast the cancer spreads. The cancer may be low grade (slow growing), intermediate grade, or high grade (fast growing).
NHL is further grouped by how the cancer cells look under the microscope, what type of white blood cell it originates from, what special tests show about it, and whether there are certain DNA changes (gene variants) in the tumor cells themselves.
Symptoms depend on what area of the body is affected by the cancer and how fast the cancer is growing.
Symptoms may include:
- Night sweats
- Fatigue
- Fever and chills that come and go
- Itching
- Swollen lymph nodes in the neck, underarms, groin, or other areas
- Weight loss
- Coughing or shortness of breath if the cancer affects the thymus gland or lymph nodes in the chest, putting pressure on the windpipe (trachea) or its branches
- Abdominal pain or swelling, leading to loss of appetite, constipation, nausea, and vomiting
- Headache, concentration problems, personality changes, or seizures if the cancer affects the brain
Treatment depends on:
- The specific type of NHL
- The stage when you are first diagnosed
- Your age and overall health
- Symptoms, including weight loss, fever, and night sweats
You may receive chemotherapy, radiation therapy, or both. Or you may not need immediate treatment. Your provider can tell you more about your specific treatment.
Radioimmunotherapy may be used in some cases. This involves linking a radioactive substance to an antibody that targets the cancerous cells and injecting the substance into the body.
A type of chemotherapy called targeted therapy may be tried. It uses a medicine to focus on specific targets (molecules) in or on cancer cells. Using these targets, the medicine disables the cancer cells so they cannot spread.
High-dose chemotherapy may be given when NHL recurs or fails to respond to the first treatment administered. This is followed by an autologous stem cell transplant (using your own stem cells) to rescue (rebuild) the bone marrow after the high-dose chemotherapy. Stem cells from donors can also be used. With certain types of NHL, these treatment steps are used at first remission to try and achieve a cure. CAR-T cell therapy (a form of immunotherapy) can be used if lymphoma comes back or does not respond to other treatments.
Blood transfusions or platelet transfusions may be required if blood counts are low.
You and your provider may need to manage other concerns during your lymphoma treatment, including:
- Having chemotherapy at home
- Managing your pets during chemotherapy
- Bleeding problems
- Dry mouth
- Eating enough calories
Fred & Pamela Buffett Cancer Center - Nebraska Medical Center
Julie Vose is a Hematologist and an Oncologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 42 years. Dr. Vose is rated as an Elite provider by MediFind in the treatment of Non-Hodgkin Lymphoma. She is also highly rated in 34 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Fred & Pamela Buffett Cancer Center - Nebraska Medical Center
Robert Bociek is an Oncologist practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 38 years. Dr. Bociek is rated as an Elite provider by MediFind in the treatment of Non-Hodgkin Lymphoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Abramson Cancer Center Perelman 4th Floor West
Stephen Schuster is a Hematologist practicing medicine in Philadelphia, Pennsylvania. Dr. Schuster is rated as an Elite provider by MediFind in the treatment of Non-Hodgkin Lymphoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Schuster is board certified in Medical Oncology, 1989, Hematology, 1986, and Internal Medicine, 1984.
You can ease the stress of illness by joining a cancer support group. Sharing with others who have common experiences and problems can help you not feel alone.
Low-grade NHL often cannot be cured by chemotherapy alone. Low-grade NHL progresses slowly and may take many years before the disease gets worse or even requires treatment. The need for treatment is usually determined by the type of lymphoma, symptoms, and how fast the disease is progressing.
Chemotherapy may cure many types of high-grade lymphomas. If the cancer does not respond to chemotherapy, the disease can cause rapid death.
NHL itself and its treatments can lead to health problems. These include:
- Autoimmune hemolytic anemia, a condition in which red blood cells are destroyed by the immune system
- Infection
- Side effects of chemotherapy medicines
Keep following up with a provider who knows about monitoring and preventing these complications.
Contact your provider if you develop symptoms of this disorder.
If you have NHL, contact your provider if you experience persistent fever or other signs of infection.
Summary: This study aims to evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells targeting B cell surface molecules including CD19 and alternative CARTs as booster and consolidation treatment for patients with highly resistant B cell lymphomas, including primary mediastinal B cell lymphoma (PMBCL) and BCL involving central nervous system (CNS-BCL)....
Summary: BACKGROUND: * A number of important scientific advances can be made through the study of blood, bone marrow, tumor, or other tissue samples from patients with HIV infection, infection with Kaposi s sarcoma associated herpesvirus (KSHV), infection with other oncogenic viruses, or cancer. * This protocol provides a mechanism to affect a variety of such studies. OBJECTIVES: -Acquisition of serum, cir...
Published Date: February 03, 2025
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Abramson JS. Non-Hodgkin lymphomas. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 103.
National Cancer Institute website. Childhood non-Hodgkin lymphoma treatment (PDQ) - health professional version. www.cancer.gov/types/lymphoma/hp/child-nhl-treatment-pdq. Updated April 17, 2025. Accessed April 22, 2025.
National Cancer Institute website. Indolent B-cell non-Hodgkin lymphoma treatment (PDQ) - health professional version. www.cancer.gov/types/lymphoma/hp/indolent-b-cell-lymphoma-treatment-pdq. Updated March 21, 2025. Accessed April 22, 2025.
Vose JM, Armitage JO. Non-Hodgkin lymphomas. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 171.


